Sulforhodamine B colorimetric assay for cytotoxicity screening

Nature Protocols

Volumn 1, Issue 3, 2006, Pages 1112-1116

  Vichai, Vanicha ^a   Kirtikara, Kanyawim ^a  

^a NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCENT DYE; LISSAMINE RHODAMINE B; RHODAMINE; UNCLASSIFIED DRUG;

ARTICLE; CELL COUNT; COLORIMETRY; CULTURE TECHNIQUE; METABOLISM; METHODOLOGY; SENSITIVITY AND SPECIFICITY; TOXICITY TESTING;

CELL COUNT; CELL CULTURE TECHNIQUES; COLORIMETRY; FLUORESCENT DYES; RHODAMINES; SENSITIVITY AND SPECIFICITY; TOXICITY TESTS;

EID: 34347230544     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2006.179     Document Type: Article

References (15)

1. Skehan, P. et al. New calorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 82, 1107-1112 (1990).
2. Lillie, R.H.J. Conn's Biological Stains 9th edn (Williams & Wilkins, Baltimore, 1977).
3. McCaffrey, T., Agarwal, L. & Weksler, B. A rapid fluorometric DNA assay for the measurement of cell density and proliferation in vitro. In Vitro Cell Dev. Biol. 24, 247-252 (1988).
4. Monks, A. et al. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J. Natl. Cancer Inst. 83, 757-766 (1991).
5. McLaren, C., Ellis, M. & Hunter, G. A calorimetric assay for the measurement of the sensitivity of herpes simplex viruses to antiviral agents. Antiviral Res. 3, 223-234 (1983).
6. Kleymann, G. & Werling, H. A generally applicable, high-throughput screening-compatible assay to identify, evaluate, and optimize antimicrobial agents for drug therapy. J. Biomol. Screen 9, 578-587 (2004).
7. Pittayakhajonwut, P. et al. An anti-herpes simplex virus-type 1 agent from Xylaria mellisii (BCC1005). Tetrahedron Lett. 46, 1341-1344 (2005).
8. Griffon, G., Merlin, J. & Marchal, C. Comparison of sulforhodamine B, tetrazolium and clonogenic assays for in vitro radiosensitivity testing in human ovarian cell lines. Anticancer Drugs 6, 115-123 (1995).
9. Pauwels, B. et al. Comparison of the sulforhodamine B assay and the clonogenic assay for in vitro chemoradiation studies. Cancer Chemother. Pharmacol. 51, 221-226 (2003).
10. Plumb, J., Milroy, R. & Kaye, S. Effects of the pH dependence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide-formazan absorption on chemosensitivity determined by a novel tetrazolium-based assay. Cancer Res. 49, 4435-4440 (1989).
11. Rubinstein, L.V. et al. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. J. Natl. Cancer Inst. 82, 1113-1117 (1990).
12. Haselsberger, K., Peterson, D., Thomas, D. & Darling, J. Assay of anticancer drugs in tissue culture: Comparison of a tetrazolium-based assay and a protein binding dye assay in short-term cultures derived form human malignant glioma. Anticancer Drugs 7, 331-338 (1996).
13. Perez, R., Godwin, A., Handel, L. & Hamilton, T. A comparison of clonogenic, microtetrazolium and sulforhodamine B assays for determination of cisplatin cytotoxicity in human ovarian carcinoma cell lines. Eur. J. Cancer 29A, 395-399 (1993).
14. Keepers, Y. et al. Comparison of the sulforhodamine B protein and tetrazolium (MIT) assays for in vitro chemosensitivity testing. Eur. J. Cancer 27, 897-900 (1991).
15. Huang, H., Shu, S., Shih, J., Kuo, C. & Chiu, I. Antimony trichloride induces DNA damage and apoptosis in mammalian cells. Toxicology 129, 113-123 (1998).